For me, our geographic diversity is a clear positive as we are not solely dependent on a single economy. About 40% of our global revenues come from the U.S., where revenues grew by 2%. Revenues from our other established market grew by 3%, while our growth in our emerging and international market was double-digit. Specifically, the growth in the BRIC countries was over 20%. We also have a broad product range. We are not just about hip and knee implants, which only account for just over 1/3 of our revenues. This is shown on the chart on the right. Here, you can see the relative performance of our global product franchises in particular. This clearly illustrates the good results in knee implants, Sports Medicine Joint Repair and Advanced Wound Management.
Smith & Nephew Management Discusses Q1 2012 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts